China Universal Asset Management Co., Ltd. Crispr Therapeutics Ag Transaction History

China Universal Asset Management Co., Ltd.

$1.03 Billion
Q2 2025

A detailed history of China Universal Asset Management Co., Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 17,346 shares of CRSP stock, worth $1.18 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

17,346

Previous 17,205 0.82%

Holding current value

$1.18 Million

Previous $585,000 44.1%

% of portfolio

0.08%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 28, 2025	BUY	$31.27 - $48.64 $4,409 - $6,858	141 Added 0.82%	17,346 $843,000
Q1 2025 Apr 29, 2025	SELL	$34.03 - $53.02 $30,388 - $47,346	-893 Reduced 4.93%	17,205 $585,000
Q4 2024 Jan 23, 2025	BUY	$38.65 - $55.15 $66,362 - $94,692	1,717 Added 10.48%	18,098 $712,000
Q3 2024 Oct 25, 2024	BUY	$44.62 - $62.75 $285,791 - $401,913	6,405 Added 64.2%	16,381 $769,000
Q2 2024 Jul 19, 2024	SELL	$51.17 - $68.18 $278,006 - $370,421	-5,433 Reduced 35.26%	9,976 $538,000
Q1 2024 Apr 29, 2024	BUY	$60.67 - $89.12 $377,124 - $553,969	6,216 Added 67.62%	15,409 $1.05 Million
Q4 2023 May 21, 2024	SELL	$38.62 - $72.18 $240,061 - $448,670	-6,216 Reduced 40.34%	9,193 $575,000
Q4 2023 Jan 23, 2024	BUY	$38.62 - $72.18 $276,210 - $516,231	7,152 Added 350.42%	9,193 $575,000
Q3 2023 May 21, 2024	BUY	$45.39 - $59.0 $45,707 - $59,413	1,007 Added 97.39%	2,041 $92,000
Q3 2023 Oct 30, 2023	BUY	$45.39 - $59.0 $45,707 - $59,413	1,007 Added 97.39%	2,041 $93,000
Q2 2023 May 21, 2024	SELL	$43.47 - $67.77 $1,347 - $2,100	-31 Reduced 2.91%	1,034 $58,000
Q2 2023 Jul 27, 2023	SELL	$43.47 - $67.77 $1,347 - $2,100	-31 Reduced 2.91%	1,034 $58,000
Q1 2023 May 21, 2024	SELL	$41.0 - $56.12 $103,853 - $142,151	-2,533 Reduced 70.4%	1,065 $48,000
Q1 2023 Apr 27, 2023	SELL	$41.0 - $56.12 $103,853 - $142,151	-2,533 Reduced 70.4%	1,065 $48,000
Q4 2022 May 21, 2024	SELL	$39.19 - $65.67 $462,873 - $775,628	-11,811 Reduced 76.65%	3,598 $146,000
Q4 2022 Jan 31, 2023	SELL	$39.19 - $65.67 $822,402 - $1.38 Million	-20,985 Reduced 85.36%	3,598 $146,000
Q3 2022 Oct 21, 2022	BUY	$61.1 - $83.78 $1.42 Million - $1.95 Million	23,250 Added 1744.19%	24,583 $1.61 Million
Q1 2022 Apr 25, 2022	BUY	$53.19 - $79.24 $70,902 - $105,626	1,333 New	1,333 $84,000

Others Institutions Holding CRSP

# of Institutions

532

Shares Held

68.7M

Call Options Held

3.67M

Put Options Held

2.25M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $5.28B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account

China Universal Asset Management Co., Ltd. Crispr Therapeutics Ag Transaction History